Related Experiment Video
Updated: Feb 16, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
MicroRNA-200a activates Nrf2 signaling to protect osteoblasts from dexamethasone
Sai Zhao1, Li Mao2, Shou-Guo Wang3
1Department of Pediatrics, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, China.
Abstract:
Treatment with dexamethasone in human osteoblasts leads to oxidative stress and cell injures. NF-E2-related factor 2 (Nrf2) is a key anti-oxidant signaling. We want to induce Nrf2 activation via microRNA-mediated silencing its suppressor Keap1. Our results show that microRNA-200a ("miR-200a") expression depleted Keap1, causing Nrf2 protein stabilization in OB-6 osteoblastic cells. Reversely, the miR-200a anti-sense led to Keap1 upregulation and Nrf2 degradation. miR-200a expression activated Nrf2 signaling, which inhibited dexamethasone-induced reactive oxygen species production and OB-6 cell death/apoptosis. Keap1 shRNA also activated Nrf2 and protected OB-6 cells from dexamethasone. Importantly, miR-200a was in-effective in Keap1-silenced (by shRNA) OB-6 cells. In the primary human osteoblasts, Keap1 silence by targeted-shRNA or miR-200a protected cells from dexamethasone. Significantly, miR-200a level was decreased in necrotic femoral head tissues, which was correlated with Keap1 mRNA upregulation. Together, miR-200a expression activates Nrf2 signaling and protects human osteoblasts from dexamethasone.
Insights
MicroRNA-200a activates the antioxidant Nrf2 pathway by targeting Keap1, protecting human osteoblasts from dexamethasone-induced oxidative stress and cell death.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Dexamethasone treatment causes oxidative stress and injury in human osteoblasts.
- NF-E2-related factor 2 (Nrf2) is a crucial signaling pathway for antioxidant defense.
- Keap1 is a negative regulator of Nrf2.
Purpose of the Study:
- To investigate the potential of microRNA-mediated Keap1 silencing to activate Nrf2 signaling.
- To determine if microRNA-200a can protect human osteoblasts from dexamethasone-induced damage.
Main Methods:
- Utilized OB-6 osteoblastic cells and primary human osteoblasts.
- Employed microRNA-200a mimics and anti-sense oligonucleotides.
- Used Keap1 shRNA for gene silencing.
- Assessed reactive oxygen species (ROS) production and apoptosis.
- Analyzed miR-200a and Keap1 levels in necrotic femoral head tissues.
Main Results:
- MicroRNA-200a (miR-200a) depletion of Keap1 led to Nrf2 stabilization in OB-6 cells.
- miR-200a activated Nrf2 signaling, inhibiting dexamethasone-induced ROS production and apoptosis.
- Keap1 silencing via shRNA or miR-200a protected primary human osteoblasts from dexamethasone.
- Decreased miR-200a levels correlated with increased Keap1 mRNA in necrotic femoral head tissues.
Conclusions:
- miR-200a activates the Nrf2 antioxidant pathway by suppressing Keap1.
- miR-200a protects human osteoblasts from dexamethasone-induced oxidative stress and cell death.
- This pathway represents a potential therapeutic target for conditions involving osteoblast injury.
Related Concept Videos
MicroRNAs
MicroRNAs
Protection of Alcohols
Protection
It defines a protecting group as the masking agent to make the more reactive species inert to a given set of conditions. This concept is depicted via the illustration of liquid flow through different outlets in an assembly of pipes. The analogy helps to understand the role...
Zones of Protection
Protective zones are defined by closed dashed lines, containing one or more components. A key characteristic of these zones is the strategic placement of...
Protecting Self-Esteem
Radial System Protection
In a radial system with a fault downstream of the third breaker, ideally, only the third breaker will open, isolating the fault and interrupting the load connected beyond it. The second breaker has a longer delay setting,...

